|
|
|
|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | A61K 9/19 | (2006.01) |
| A61K 47/10 | (2017.01) | ||
| A61K 47/26 | (2006.01) | ||
| A61K 47/18 | (2017.01) | ||
| A61K 38/19 | (2006.01) |
| (11) | Number of the document | 3681483 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18779167.8 |
| Date of filing the European patent application | 2018-09-10 | |
| (97) | Date of publication of the European application | 2020-07-22 |
| (45) | Date of publication and mention of the grant of the patent | 2022-05-18 |
| (46) | Date of publication of the claims translation | 2022-09-12 |
| (86) | Number | PCT/US2018/050305 |
| Date | 2018-09-10 |
| (87) | Number | WO 2019/055357 |
| Date | 2019-03-21 |
| (30) | Number | Date | Country code |
| 201762559420 P | 2017-09-15 | US |
| (72) |
TALLEY, Clea , US
|
| (73) |
Amgen Inc. ,
One Amgen Center Drive, Thousand Oaks, California 91320-1799,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Terapinio baltymo farmacinės formos liofilizavimo būdas |
| PROCESS FOR LYOPHILIZED PHARMACEUTICAL FORMULATION OF A THERAPEUTIC PROTEIN |
| Payment date | Validity (years) | Amount | |
| 2025-08-20 | 8 | 185.00 EUR |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2025-08-28 |